Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV

South Africa Time — Wednesday, August 08, 2018

Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV
- China National Drug Administration (CNDA) has approved Genvoya(elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg/tenofovir ...

LEGACY - for researchers

Top stories of the last 30 days

FDA slaps clinical hold on multiple Gilead HIV trials

South Africa Time — Wednesday, June 11, 2025

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...

HIV Prevention Has a Fantastic New Treatment

South Africa Time — Thursday, June 26, 2025

A new HIV prevention vaccine, Yezturgo Lenacapavir, is not a cure but taken twice a year, the treatment provides 99.9% protection. View article...

Nigeria : New HIV Drug May Exclude Vulnerable Populations

South Africa Time — Tuesday, June 24, 2025

The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...

Weight Regain After GLP-1 Discontinuation is Less Rapid in Real World: Hamlet Gasoyan, PhD

South Africa Time — Tuesday, June 24, 2025

The prevention of HIV could monumentally shift followong the FDA approval of lenacapavir on June 19, as the twice-yearly long-acting injectable form ... View article...

HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study

South Africa Time — Thursday, June 19, 2025

The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...

US FDA places clinical hold on Gilead trials testing HIV pill combination

South Africa Time — Wednesday, June 11, 2025

The U.S. Food and Drug Administration has placed a clinical hold on Gilead Sciences' trials testing a combination of two of its experimental HIV ... View article...

Beetle-powered TB test aids diagnosis in HIV patients

South Africa Time — Wednesday, July 02, 2025

A credit card-sized tuberculosis test that works without electricity has shown 87 per cent accuracy in detecting TB among people living with HIV . View article...

Kenya's war on HIV, TB and malaria faces setback as funding drops sharply

South Africa Time — Tuesday, June 17, 2025

A nearly 40 per cent cut in government funding for Global Fund-backed health programmes is threatening to undermine Kenya's fight against HIV , TB, and ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2025 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Beetle-powered TB test aids diagnosis in HIV patients

South Africa Time — Wednesday, July 02, 2025

A credit card-sized tuberculosis test that works without electricity has shown 87 per cent accuracy in detecting TB among people living with HIV . View article...

Knowledge, Attitudes, and Practices of Nurses Regarding Needle Stick Injuries, HIV, and ...

South Africa Time — Wednesday, July 02, 2025

Introduction. Needlestick injuries (NSIs) pose serious health risks to healthcare workers, especially nurses, due to the potential transmission of HIV ... View article...

HIV prevalence in Libya remains low, says NCDC

South Africa Time — Wednesday, July 02, 2025

... the NCDC reported that by the end of 2024, the total number of confirmed HIV cases reached approximately 8271, including 369 new cases that year. View article...

ICMR study flags HIV burden in South India; 54 high-priority districts identified

South Africa Time — Wednesday, July 02, 2025

In 2023, an estimated 68.45 thousand new HIV Infections occurred in India. According to the studies, Karnataka, Telangana and Tamil Nadu contributed ... View article...

Nearly 75% of pivotal cancer trials in past 5 years exclude people living with HIV

South Africa Time — Wednesday, July 02, 2025

From 2020 to 2024, 72.6% of pivotal oncology trials excluded people living with HIV ; Trials for blood cancers, immunomodulatory agents and those ... View article...

Decline of Nonrecommended HIV Care in Medicare

South Africa Time — Wednesday, July 02, 2025

A recent study shows a substantial decline in the use of nonrecommended antiviral prescriptions among Medicare beneficiaries with HIV . View article...

Can South Africa's HIV fight survive the US funding pull-out?

South Africa Time — Wednesday, July 02, 2025

South Africa's HIV programme is the biggest in the world, but now it's been cut thin, with the loss of billions in US funding. View article...

Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases

South Africa Time — Thursday, July 03, 2025

One of the highlights regarding HIV prevention was a study looking at lenacapavir (LEN; Gilead) once yearly for pre-exposure prophylaxis (PrEP). (LEN ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews